A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy. (September 2017)

• Record Type: Journal Article
• Authors: Kalantari, Shiva; Nafar, Mohsen
• Is Part Of: Biomarkers in medicine. Volume 11:Number 9(2017)
• Page Start: 781
• Page End: 797
• Publication Date: 2017-09
• Subjects: anti-PLA2R -- auto-antibodies -- complement pathway -- diagnostic biomarkers -- idiopathic -- immune complex -- membranous nephropathy -- metabolomics -- proteomics -- transcriptomics; Biochemical markers -- Periodicals; 610.28
• DOI: 10.2217/bmm-2017-0081
• Languages: English
• ISSNs: 1752-0363

Abstract

Membranous nephropathy (MN) is relatively major cause of nephrotic syndrome in adults which is recognized as an organ-specific autoimmune disease. The etiology of most cases is idiopathic, whereas the secondary MN is caused by systemic autoimmune diseases, infections, medications and malignancies. The idiopathic disease is developed by the formation of sub-epithelial immune complex deposits most likely due to binding the circulating auto-antibodies to intrinsic antigen on podocytes. The major auto antibody is the anti-phospholipase A2 receptor (anti-PLA2R), however, it is not enough sensitive. Several attempts for diagnostic biomarker identification by modern analytical technologies have been devoted recently. This article reviews the biomarker candidates for primary type of MN that are detected by different approaches on human subjects.